KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL

AUO showcases its smart healthcare solutions at the 2024 Healthcare+ Expo Taiwan, including 3D surgical imaging, AI-assisted diagnosis, and smart dental integration. ADP introduces a 3D smart surgical imaging platform for real-time imaging synchronization and remote robotic control. DentLabX launches a Smart Dental Lab Management Suite, and AUO Health debuts Taiwan's first portable pulse detector for TCM diagnostics.

EVER-132-002 study, compliant with Helsinki and ICH GCP guidelines, was approved by national authorities and ethics committees. It enrolled HR+HER2- metastatic or locally recurrent BC patients from China, Korea, and Taiwan, requiring prior chemotherapy and measurable disease. Patients were randomized 1:1 to receive SG or chemotherapy, with PFS as the primary endpoint. Secondary endpoints included OS, ORR, DoR, CBR, safety, and QoL. Assessments involved tumor measurements, safety evaluations, and QoL questionnaires. Statistical analysis included sample size calculation, HR estimation, and safety summaries. The study design details are available in the Nature Portfolio Reporting Summary.